Carmax Proves Its No Lemon

“Let me look at the Carmax results, when it came out to its earnings, higher on its earnings, better than expected figures. Ex-items for accounting purposes once you work through that come up with a comparable number, $0.44 a share versus an estimated $0.18, revenue better than expected, $2.08 billion given in large part by the cash for clunkers program. The used car retailer is doing very well, the stock has more than doubled.” — Fox Business Network 9/22/2009

Carmax (NYSE:KMX) rode improved unit sales in both used and wholesale vehicles to a much better quarter than Wall Street had expected. In the company’s second quarter ended August 31, sales were up 13% to $2.08 billion easily outpacing estimates for a drop of 4% that analysts had expected. Same store sales rose by 8%, which is far better than the 17% declines seen in the first quarter.

Some of the credit for this is attributed indirectly to cash for clunkers. One analyst speculated that some of the increased foot traffic was from buyers who were interested in purchasing a car on the government’s program, but some of these interested buyers were unable to qualify for the credit. As the theory goes, some of those buyers turned to the cheaper alternative of Carmax to scratch the car-buying itch. The store traffic and sales numbers seem to back up this indirect benefit.

No matter the reason, the results are tough to dispute. Carmax’s earnings rose more than 7-fold to $.46 per share compared to the extremely weak quarter a year ago which netted the company only 6 cents per share. Analysts had expected more modest earnings growth to 18 cents per share. Also, KMX was helped by much better performance from Carmax Auto Finance unit which saw net income of $72 million compared with a loss of more than $7 million last year. Adjustments to loans originated in previous quarters resulted in a large one-time gain of $36.2 million.

Better sales and strict cost controls enabled Carmax to outperform analysts expectations, and the indirect effect from the government’s Cash for Clunkers program was bigger than almost anyone had imagined. Not surprisingly, the stock has roared higher today, up more than 9% in midday trading. At Ockham, we are reiterating our neutral or Fairly Valued rating at this time. The results for the quarter were far better than we had anticipated, but much of that performance is already reflected in the price. Given the current fundamentals, we think that a price around $19 would be reasonable to expect going forward.

Furthermore, we have concerns that Carmax could experience some clunky sales going forward as a hangover from Cash for Clunkers. A report from Edmonds.com shows that post-clunker sales have hit a 28-year low to a rate of 8.8 million units per year. This is a 38% plunge from last month, and suggests that the government’s incentives simply pulled demand forward. This effect will likely be less direct for Carmax than it will be for the new car dealers, but as we saw with this quarters results Carmax is not immune from the effects of government intervention on the car-buying market.

Carmax could certainly benefit from U.S. consumers saving more and spending less, which would translate to more modest car purchases. However, with a very rich valuation multiple of 33x based on trailing four quarters, we would recommend taking profits in a stock that is up more than 200% in less than a year. It will take some mighty impressive quarters to simply maintain this price, much less continue higher.

Carmax Proves Its No Lemon Posting a Much Better 2Q

About Ockham Research 645 Articles

Ockham Research is an independent equity research provider based in Atlanta, Georgia. Security analysis at Ockham Research is based upon the principle known as Ockham's Razor, named for the 14th- century Franciscan friar, William of Ockham. The principle states that a useful theory should utilize as few elements as possible, because efficiency is valuable. In this spirit, our goal is to make the investing environment as simple and understandable as possible, yet no simpler than is necessary.

We utilize this straightforward approach to value over 5500 securities, with key emphasis given to the study of individual securities' price-to-sales, price-to-cash earnings and other historical valuation ranges. Our long term value investing methodology is powered by the teachings of Ben Graham and it has proven to be very adept at identifying stock prices that are out of line with fundamental factors.

Ockham Research provides its research in a variety of forms and products including our company specific reports, portfolio analytics tools, newsletters, and blog posts. We also offer a white labeling research solution that can give any financial services firm their own research presence without the time and cost associated with building such a robust coverage universe of their own.

Be the first to comment

Leave a Reply

Your email address will not be published.


*